Atom Investors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,800
| Closed | -$1.17M | – | 468 |
|
|
2024
Q2 | $1.17M | Buy |
4,800
+663
| +16% | +$161K | 0.12% | 226 |
|
|
2024
Q1 | $618K | Buy |
+4,137
| New | +$618K | 0.08% | 296 |
|
|
2023
Q2 | – | Sell |
-7,533
| Closed | -$1.51M | – | 290 |
|
|
2023
Q1 | $1.51M | Buy |
7,533
+6,135
| +439% | +$1.23M | 0.82% | 25 |
|
|
2022
Q4 | $332K | Sell |
1,398
-5,289
| -79% | -$1.26M | 0.17% | 127 |
|
|
2022
Q3 | $1.34M | Sell |
6,687
-228
| -3% | -$45.6K | 0.47% | 60 |
|
|
2022
Q2 | $1.01M | Buy |
+6,915
| New | +$1.01M | 0.44% | 66 |
|